# OnCo record vizenpistat (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/vizenpistat/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "vizenpistat" ;
  schema:name "Vizenpistat"@en ;
  schema:alternateName "SR-8541A"@en, "SR8541A"@en ;
  schema:description "Vizenpistat is an experimental tablet from Stingray Therapeutics that aims to restore an early immune alarm many tumours switch off. It is in early trials, including one with two immunotherapy antibodies in bowel cancer."@en ;
  schema:url <https://onco.cc/drugs/vizenpistat/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.stingraytx.com/science>, <https://clinicaltrials.gov/study/NCT06589440>, <https://clinicaltrials.gov/study/NCT06063681> ;
  onco:status "phase-2" ;
  onco:tag "pipeline" ;
  onco:modality "Oral small-molecule ENPP1 inhibitor" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:companies <https://onco.cc/companies/stingray-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct06589440/> .